Kenfarb & Co’s GSK GSK Stock Holding History

Kenfarb & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$339K	Hold	9,360	–	–	0.31%	77
2023 Q2	$333K	Hold	9,360	–	–	0.29%	79
2023 Q1	$333K	Hold	9,360	–	–	0.3%	79
2022 Q4	$329K	Hold	9,360	–	–	0.29%	80
2022 Q3	$275K	Hold	9,360	–	–	0.26%	84
2022 Q2	$510K	Hold	9,360	–	–	0.4%	65
2022 Q1	$510K	Hold	9,360	–	–	0.4%	65
2021 Q4	$516K	Buy	+9,360	New	+$487K	0.38%	64

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kenfarb & Co's GSK Position: Q3 2023 in Review

Kenfarb & Co held its GSK (GSK) position steady in Q3 2023 at 9,360 shares worth $339K. The position accounts for 0.31% of the portfolio, ranked #77.

Kenfarb & Co first reported a position in GSK in Q4 2021 and has held it in 8 quarters since. The position peaked at $516K in Q4 2021. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Kenfarb & Co held 9,360 shares of GSK worth $339K as of Q3 2023.
Kenfarb & Co left its GSK share count unchanged in Q3 2023.
GSK made up 0.31% of Kenfarb & Co's portfolio in Q3 2023, its #77 holding.
Kenfarb & Co first reported a position in GSK in Q4 2021 and has held it in 8 quarters since.
Kenfarb & Co's GSK position peaked at $516K in Q4 2021.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.